Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.
Nat Med. 2019 Jul;25(7):1073-1081. doi: 10.1038/s41591-019-0499-y. Epub 2019 Jul 3.
Nat Med. 2019.
PMID: 31270502